CLINICAL_TRIALS trial_result · 2025-09-12

Clinical Trial Update: Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast

The trial evaluating management of ductal carcinoma in situ or lobular carcinoma in situ has completed and its results were posted on 2025-09-12.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Institut Bergonié | Conditions: Intraductal Carcinoma and Lobular Carcinoma in Situ | Status: COMPLETED | Results posted: 2025-09-12